Impact of screening, diagnosis and treatment strategies on cervical cancer mortality in Brazil

Impacto do rastreio, diagnóstico e tratamento na mortalidade por câncer de colo de útero no Brasil

Authors

DOI:

https://doi.org/10.17765/2176-9206.2025v18e13129

Keywords:

cervical cancer, mortality, health services accessibility

Abstract

Objective: to analyze the impact of screening, diagnosis and treatment on cervical cancer mortality in Brazil in 2009 and 2019. Method: The dependent variable was the cervical cancer mortality rate, and the independent variables were coverage of cytopathological examination, proportion of late diagnoses and time between diagnosis and treatment. The panel data model was used considering the 27 Brazilian federation units and the year as a time variable. Results: the mortality rate from cervical cancer varied from 8.57 deaths per 100 thousand women in 2009 to 7.93 deaths per 100 thousand women in 2019 and this subtle reduction did not show a statistically significant relationship with the independent variables. Conclusion: indicators related to screening, diagnosis and treatment did not impact mortality rates from cervical cancer.

Downloads

Download data is not yet available.

Author Biographies

Sara Rafaela Valcácio Camargo, Federal University of Rio Grande do Norte

Master's student in Public Health at the Federal University of Rio Grande do Norte (UFRN), with a solid background in Nursing from the same institution. During her undergraduate studies, she distinguished herself as a teaching assistant in crucial subjects such as Human Morphology and Physiology, Biostatistics, and Health and Citizenship. Before entering the health field, she completed her secondary and technical education in Mechanics at the Federal Institute of Rio Grande do Norte (IFRN), where she developed a Final Course Project that demonstrated her ability to integrate technical knowledge of mechanics with specialized English language skills. Her areas of interest include Women's Health, Epidemiology, and Health Technologies. Demonstrating a strong commitment to academic excellence and innovation, she seeks to apply her interdisciplinary knowledge to promote significant advances in the field of public health.

Ana Karoline de Freitas Nascimento, Federal University of Rio Grande do Norte

Registered Nurse from the Federal University of Rio Grande do Norte/Faculty of Health Sciences of Trairi (UFRN/FACISA). Mechanical Technician from the Federal Institute of Education, Science and Technology of Rio Grande do Norte (IFRN). Master's student in the Postgraduate Program in Public Health (PPGSaCol). During her undergraduate studies, she participated in monitoring programs in the subjects of Human Morphology and Physiology, Health and Citizenship, Biostatistics, and Epidemiology. Her research interests lie in the areas of racial issues, Public Health, Child Health, and Social Determinants. She works as a Nurse in the Family Health Strategy at the Bonsucesso Basic Health Unit.

Isabelle Ribeiro Barbosa, Federal University of Rio Grande do Norte

She is a professor at the Federal University of Rio Grande do Norte. She specializes in Epidemiology and holds a PhD in Public Health from UFRN, with a research internship at the University of Zaragoza (Spain). She is a CNPq Research Productivity Fellow (Level II). She is a permanent faculty member of the Postgraduate Program in Public Health at the Health Sciences Center of UFRN and the Postgraduate Program in Public Health at the Faculty of Health Sciences of Trairi/UFRN. She has experience in the areas of Public Health with an emphasis on Epidemiology, in the following research topics: Epidemiology of inequalities in health conditions and access to health services, Health of the Black population, Mental health and violence. She has worked at the Ministry of Human Rights and Citizenship (MDHC) in Brasília-DF, in the National Secretariat for the Rights of Older Persons, in the General Coordination of Policies for the Rights of Older Persons in Situations of Vulnerability and Multiple Discrimination, and has served on the National Council for the Rights of Older Persons (CNDPI).

References

1. World Health Organization. Cancer today [Internet]. IARC; 2020. Disponível em: https://gco.iarc.fr/today/home

2. Instituto Nacional de Câncer (INCA). Estimativa 2020: incidência de câncer no Brasil [Internet]. 2019. Disponível em: https://www.inca.gov.br/publicacoes/livros/estimativa-2020-incidencia-de-cancer-no-brasil

3. Instituto Nacional de Câncer (INCA). HPV [Internet]. [citado em 2024 Nov 26]. Disponível em: https://www.gov.br/inca/pt-br/acesso-a-informacao/perguntas-frequentes/hpv

4. Peng Q, Wang L, Zuo L, Gao S, Jiang X, Han Y, et al. HPV E6/E7: insights into their regulatory role and mechanism in signaling pathways in HPV-associated tumor. Cancer Gene Ther. 2024;31(1):9-17. https://doi.org/10.1038/s41417-023-00682-3

5. Castle PE, Einstein MH, Sahasrabuddhe VV. Cervical cancer prevention and control in women living with human immunodeficiency virus. CA Cancer J Clin. 2021;71(6):505-26. https://doi.org/10.3322/caac.21696

6. dos Santos JN, Gomes RS. Sentidos e percepções das mulheres acerca das práticas preventivas do câncer do colo do útero: revisão integrativa da literatura. Rev Bras Cancerol. 2022;68(2):1-9. https://doi.org/10.32635/2176-9745.RBC.2022v68n2.1632

7. Teixeira LA. From gynaecology offices to screening campaigns: a brief history of cervical cancer prevention in Brazil. Hist Cienc Saude Manguinhos. 2015;22(1):221-39. https://doi.org/10.1590/S0104-59702015000100013

8. Instituto Nacional de Câncer (INCA). Câncer do colo do útero [Internet]. 2018 [citado em 2024 Nov 26]. Disponível em: https://www.inca.gov.br/tipos-de-cancer/cancer-do-colo-do-utero/profissional-de-saude

9. Gomes DS, Maciel JM, Santos SMS, de Sales JKD, Rodrigues LM, Callou RDSBL, et al. Fatores que interferem na não adesão de mulheres ao teste de Papanicolaou: revisão integrativa. Rev Eletrônica Acervo Saúde. 2021;13(12):e9278. https://doi.org/10.25248/reas.e9278.2021

10. Buskwofie A, David-West G, Clare CA. A review of cervical cancer: incidence and disparities. J Natl Med Assoc. 2020;112(2):229-32. https://pubmed.ncbi.nlm.nih.gov/32278478/

11. Brasil. Ministério da Saúde. Portaria Nº 2.439, de 8 de dezembro de 2005. Institui a Política Nacional de Atenção Oncológica: promoção, prevenção, diagnóstico, tratamento, reabilitação e cuidados paliativos. Diário Oficial da União. 2005 Dez 9; Seção 1:80.

12. Zhou Y, Rassy E, Coutte A, Achkar S, Espenel S, Genestie C, et al. Current standards in the management of early and locally advanced cervical cancer: update on the benefit of neoadjuvant/adjuvant strategies. Cancers. 2022;14(10):2449. https://doi.org/10.3390/cancers14102449

13. Brasil. Lei nº 12.732, de 22 de novembro de 2012. Dispõe sobre o primeiro tratamento de paciente com neoplasia maligna comprovada e estabelece prazo para seu início. Diário Oficial da União. 2012 Nov 23; Seção 1:80.

14. Tran KB, Lang JJ, Compton K, Xu R, Acheson AR, Henrikson HJ, et al. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022;400(10352):563-91. https://doi.org/10.1016/S0140-6736(22)01438-6

15. Santos CA, Souza DLB. Melanoma mortality in Brazil: trends and projections (1998-2032). Cien Saude Colet. 2019;24(4):1551-61. https://doi.org/10.1590/1413-81232018244.13932017

16. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335-51. https://doi.org/10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z

17. Instituto Nacional de Câncer (INCA). Ficha técnica de indicadores das ações de controle do câncer do colo do útero [Internet]. 2014. Disponível em: https://www.inca.gov.br/sites/ufu.sti.inca.local/files/media/document/fichatecnicaindicadorescolo14.pdf

18. Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. Chichester, West Sussex, UK: John Wiley & Sons; 2009.

19. Meira KC, Magnago C, Mendonça AB, Duarte SFS, de Freitas PHO, dos Santos J, et al. Inequalities in temporal effects on cervical cancer mortality in states in different geographic regions of Brazil: an ecological study. Int J Environ Res Public Health. 2022;19(9):5591. https://doi.org/10.3390/ijerph19095591

20. Barbosa IR, Souza DLB, Bernal MM, Costa ICC. Desigualdades regionais na mortalidade por câncer de colo de útero no Brasil: tendências e projeções até o ano 2030. Cien Saude Colet. 2016;21(1):253-62. https://doi.org/10.1590/1413-81232015211.03662015

21. World Health Organization. International Agency for Research on Cancer (IARC). GLOBOCAN 2020: estimated cancer incidence, mortality and prevalence worldwide [Internet]. Lyon: IARC; 2020. Disponível em: http://globocan.iarc.fr

22. Ferreira MDCM, Nogueira MC, Ferreira LDCM, Bustamante-Teixeira MT. Detecção precoce e prevenção do câncer do colo do útero: conhecimentos, atitudes e práticas de profissionais da ESF. Cien Saude Colet. 2022;27:2291-302. https://doi.org/10.1590/1413-81232022276.17002021

23. Maciel NS, Luzia FJM, Ferreira DS, Ferreira LCC, Mendonça VM, Oliveira AWN, et al. Busca ativa para aumento da adesão ao exame Papanicolaou. Rev Enferm UFPE On Line. 2021;15(1):e245678. https://doi.org/10.5205/1981-8963.2021.245678

24. Fedrizzi EM, Ponce NM. Coverage of pap smear and mortality from cervical cancer in Brazil from 2006 to 2014. Braz J STD. 2017;29(4):117-24. https://doi.org/10.5533/DST-2177-8264-201729402

25. Santos TBD, Borges AKDM, Ferreira JD, Meira KC, Souza MCD, Guimarães RM, et al. Prevalência e fatores associados ao diagnóstico de câncer de mama em estágio avançado. Cien Saude Colet. 2022;27(2):471-82. https://doi.org/10.1590/1413-81232022272.36462020

26. Herbert A, Singh N, Smith JAE. Adenocarcinoma of the uterine cervix compared with squamous cell carcinoma: a 12-year study in Southampton and South-west Hampshire. Cytopathology. 2001;12(1):26-36. https://doi.org/10.1046/j.1365-2303.2001.00288.x

27. Oliveira NPDD, Cancela MDC, Martins LFL, Castro JLD, Meira KC, Souza DLB. Desigualdades sociais no diagnóstico do câncer do colo do útero no Brasil: um estudo de base hospitalar. Cien Saude Colet. 2024;29(6):e03872023. https://doi.org/10.1590/1413-81232024296.038720

28. Jesus ASD, Aleluia ÍRS, Sousa MLTD, Aragão MN. Coordenação do cuidado ao câncer de colo uterino pela Atenção Primária à Saúde. Physis. 2024;34:e34039. https://doi.org/10.1590/S0103-7331202434039pt

29. Frianto D, Setiawan D, Diantini A, Suwantika AA. Economic evaluations of HPV vaccination in targeted regions of low- and middle-income countries: a systematic review of modelling studies. Int J Womens Health. 2022;14:1315-22. https://doi.org/10.2147/IJWH.S367953

Downloads

Published

2025-11-23

How to Cite

Camargo, S. R. V., Nascimento, A. K. de F., & Barbosa, I. R. (2025). Impact of screening, diagnosis and treatment strategies on cervical cancer mortality in Brazil: Impacto do rastreio, diagnóstico e tratamento na mortalidade por câncer de colo de útero no Brasil. Saúde E Pesquisa, 18, e13129. https://doi.org/10.17765/2176-9206.2025v18e13129

Issue

Vol. 18 (2025)

Section

Artigos Originais

License

Copyright (c) 2025 Saúde e Pesquisa

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

A submissão de originais para a revista Saúde e Pesquisa implica na transferência da Carta Concessão de Direitos Autorais, pelos autores, dos direitos de publicação digital para a revista após serem informados do aceite de publicação.

A Secretaria Editorial irá fornecer da um modelo de Carta de Concessão de Direitos Autorais, indicando o cumprimento integral de princípios éticos e legislação específica. Os direitos autorais dos artigos publicados nesta revista são de direito do autor, com direitos da revista sobre a primeira publicação. Os autores somente poderão utilizar os mesmos resultados em outras publicações, indicando claramente a revista Saúde e Pesquisa como o meio da publicação original. Em virtude de tratar-se de um periódico de acesso aberto, é permitido o uso gratuito dos artigos, principalmente em aplicações educacionais e científicas, desde que citada a fonte. A Saúde e Pesquisa adota a licença Creative Commons Attribution 4.0 International.

A revista se reserva o direito de efetuar, nos originais, alterações de ordem normativa, ortográfica e gramatical, com vistas a manter o padrão culto da língua e a credibilidade do veículo. Respeitará, no entanto, o estilo de escrever dos autores. Alterações, correções ou sugestões de ordem conceitual serão encaminhadas aos autores, quando necessário. Nesses casos, os artigos, depois de adequados, deverão ser submetidos a nova apreciação. As opiniões emitidas pelos autores dos artigos são de sua exclusiva responsabilidade.

Crossref
Scopus
Google Scholar
Europe PMC

Most read articles by the same author(s)